Janney Montgomery Scott
NBSE

Janney Montgomery Scott’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Janney Montgomery Scott’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-26
Closed -$2K – 2146
2018
Q2 		$2K Hold
26
– – ﹤0.01% 1988
2018
Q1 		$2K Hold
26
– – ﹤0.01% 1934
2017
Q4 		$20K Hold
26
– – ﹤0.01% 1911
2017
Q3 		$8K Sell
26
-3
-10% -$819 ﹤0.01% 1821
2017
Q2 		$7K Hold
29
– – ﹤0.01% 1733
2017
Q1 		$10K Hold
29
– – ﹤0.01% 1732
2016
Q4 		$17K Sell
29
-1
-3% -$1.06K ﹤0.01% 1671
2016
Q3 		$34K Buy
+30
New +$32.4K ﹤0.01% 1510

Other funds holding NBSE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Janney Montgomery Scott's NBSE Position: Q3 2018 in Review

Janney Montgomery Scott sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q3 2018, closing a stake of 26 shares — an estimated $2K sold.

Janney Montgomery Scott first reported a position in NBSE in Q3 2016 and held it in 8 quarters. The position peaked at $34K in Q3 2016. 29 funds tracked by Wall St. Rank hold NBSE as of Q3 2018.

  • Janney Montgomery Scott reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Janney Montgomery Scott sold 26 NeuBase Therapeutics, Inc. Common Stock shares in Q3 2018, an estimated $2K.
  • Janney Montgomery Scott first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q3 2016 and held it in 8 quarters.
  • Janney Montgomery Scott's NeuBase Therapeutics, Inc. Common Stock position peaked at $34K in Q3 2016.
  • 29 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q3 2018.

Based on Janney Montgomery Scott's 13F filing for Q3 2018, filed 5 Nov 2018.